| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |